- Abbey Minogue
- Alec Cutler
- Alex Lennard
- Amanda Mark
- Andrew Lockhart
- Ashley Ryburn
- Australian Ethical
- Ben Walsh
- Brad Tank
- Catherine Evans
- Complii
- Contributor
- David Chaplin
- David Dix
- David Simon
- Drew Meredith
- Duncan Hughes
- Duncan MacInnes
- Eleanor Moriarty
- Eleece Quilliam
- Emanuel Datt
- Ferdinand Cheuk
- Fran Hughes
- Francyne Mu
- Giselle Roux
- Greg Bright
- Helen Nan
- Henry Maxey
- Hilary Frisch
- Ishan Dan
- Jacquelyn Mann
- James Dunn
- Jamie Dannhauser
- Jamie Nemtsas
- Jaxon King
- John Taylor
- Jonathan Pullin
- Jonathan Ruffer
- Jonathon Pullin
- Joss Engebretsen
- Kevin Toohey
- Kristina Hooper
- Lachlan Buur-Jensen
- Lachlan Maddock
- Lauren French
- Lauren Ryan
- Laurence Parker-Brown
- Lisa Uhlman
- Michael Armitage
- Michael Arno
- Michael Nathanson
- Mishan Dahia
- Nicholas Way
- Nick Hatzis
- Nick Langley
- Nicki Bourlioufas
- Nigel Baker
- Omar Khan
- Owen Raszkiewicz
- Penny Pryor
- Phil Strano
- Pzena Investment Management
- Rob Perrone, Eric Marais & Shane Woldendorp
- Rob Prugue
- Sandy Kaul
- Sean Graham
- Sonali Desai
- Sophie Bannerman
- Staff Writer
- Steve Russell
- Steve Sloane
- Tahn Sharpe
- The Inside Adviser
- Tim Kruger
- Tom King
- Tom Patrick
- Tom Slater
- Will Arnost
- Ye Peng
Upcoming webinars and virtual roundtables
As working from home has become the new normal for most people, there are still many opportunities for advisers and investors to cut through the noise and hear...
Financial planning daily report - ASX to open lower
The S&P/ASX 200 (ASX:XJO) is expected to open lower on Wednesday following weak leads from Wall Street.
Financial Planner morning report Tuesday
A covid cure on the horizon? US-based drugmaker Moderna revealed positive results from its human trials of a Coronavirus vaccine, treating those yet to suffer...
Financial Planner morning report Tuesday
A covid cure on the horizon? US-based drugmaker Moderna revealed positive results from its human trials of a Coronavirus vaccine, treating those yet to suffer...
Daily report Monday - from Xero to profit, ASX 200 to open up, and is retail dead?
The ASX 200 (ASX: XJO) is set to open higher, China and Australia trade tensions to ease, Xero reports and more.
Financial Planner morning report - markets in a two-step
Here's what Australian financial planners and advisers need to know on Thursday morning...
Aussie tech stocks shine
If clients are seeking advice on where opportunities are in the Australia share market, they should not overlook a group of Australian technology stocks that...
ETF Securities: FANGs defy rocky market
In hindsight, March 2nd, 2020, as the world started to get to grips with the scale of the global health emergency that was unfolding in the form of the...
Are CBA shares worth $49?
Dividends from Commonwealth Bank of Australia (ASX: CBA) shares and the ‘Big Four’ have been put under the microscope. So far, CBA has held up the...
Are CBA shares worth $49?
Dividends from Commonwealth Bank of Australia (ASX: CBA) shares and the ‘Big Four’ have been put under the microscope. So far, CBA has held up the...
Financial Planner Morning Report - Wednesday
The ASX 200 is likely to start trading lower on Wednesday, according to futures contracts in Sydney.
Financial Planner Morning Report - Wednesday
The ASX 200 is likely to start trading lower on Wednesday, according to futures contracts in Sydney.
Financial Planner Morning Report - global markets mixed
The ASX 200 is likely to open slightly lower on Tuesday according to the Sydney Futures Exchange, following mixed results from global markets overnight.
Financial Planner Morning Report - global markets mixed
The ASX 200 is likely to open slightly lower on Tuesday according to the Sydney Futures Exchange, following mixed results from global markets overnight.